B型钠尿肽的生物学特征及其研究进展(3)
[8] De winter RJ. Stroobans A, KochKT et al. Plasm N-terminal pro-B-type naturetic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention，[J] . Am J cardiol，2004，94(12):1481-1485.
[9] Wanion, Martin Do, Martouche NF, et al. Plasma B-type natriuretic peptide levels predict postopesative atrial fibrillation in patients undeogoing cardial surgery. [J] circulation, 2004, 110(2):124-127.
[10] Anwaruddin S, Lloyd Jones DM, Baggish A, Chen A,etal. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Journal of the American College of Cardiology. 2006，47(1)：546-548.
[11] 郑辉，李健雄，李卫凯. 脑钠素用于慢性充血性心力衰竭的诊断研究. 国际检验医学杂志，2006，27(5)：345-348.
[12] 张保平，宿端俊，冯新平等.血浆与血清标本检测脑钠肽的结果比较. 现代检验医学杂志，2007，22：(3)：156-158.
[13] 邱玲，和歆琦，王健等. 非均相免疫测定氨基端前B型钠尿肽的分析性能验证. 检验医学，2007，22(4)：305-306.
[14] 陈四华,张建龙,熊伟. B型钠尿肽测定在慢性心力衰竭诊治中的临床观察. 临床内科杂志，2010，27(1)：62-63.
[15] 廖予婕. cTnI、hs-CRP和BNP在心力衰竭患者治疗前后的变化及其对诊断. 检验医学， 2010， 25，(2) 92-95.
[16] Leuchte HH, Holzapfelm, Baumgartnet RA, et al. Clinical significance of brain natricretic peptide in primary pulminhary hypertension [J] . Am Jcardiol， 2004，4(5)：764-770.
[17] Parsonage WA, Galbraith AJ, Koerbin GL, et al. Value of B-type natriuretic peptide for inentfying significantly elevated pulconary artery wedge. Pressure in patients treated for established chronic kheart fuiluse seeeondury to isohemic oridiopathic dilated?cardionryopathy [J].?Am?J?cardiol 2005，95 (7)：883-885., http://www.100md.com(李玲玲)
[9] Wanion, Martin Do, Martouche NF, et al. Plasma B-type natriuretic peptide levels predict postopesative atrial fibrillation in patients undeogoing cardial surgery. [J] circulation, 2004, 110(2):124-127.
[10] Anwaruddin S, Lloyd Jones DM, Baggish A, Chen A,etal. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Journal of the American College of Cardiology. 2006，47(1)：546-548.
[11] 郑辉，李健雄，李卫凯. 脑钠素用于慢性充血性心力衰竭的诊断研究. 国际检验医学杂志，2006，27(5)：345-348.
[12] 张保平，宿端俊，冯新平等.血浆与血清标本检测脑钠肽的结果比较. 现代检验医学杂志，2007，22：(3)：156-158.
[13] 邱玲，和歆琦，王健等. 非均相免疫测定氨基端前B型钠尿肽的分析性能验证. 检验医学，2007，22(4)：305-306.
[14] 陈四华,张建龙,熊伟. B型钠尿肽测定在慢性心力衰竭诊治中的临床观察. 临床内科杂志，2010，27(1)：62-63.
[15] 廖予婕. cTnI、hs-CRP和BNP在心力衰竭患者治疗前后的变化及其对诊断. 检验医学， 2010， 25，(2) 92-95.
[16] Leuchte HH, Holzapfelm, Baumgartnet RA, et al. Clinical significance of brain natricretic peptide in primary pulminhary hypertension [J] . Am Jcardiol， 2004，4(5)：764-770.
[17] Parsonage WA, Galbraith AJ, Koerbin GL, et al. Value of B-type natriuretic peptide for inentfying significantly elevated pulconary artery wedge. Pressure in patients treated for established chronic kheart fuiluse seeeondury to isohemic oridiopathic dilated?cardionryopathy [J].?Am?J?cardiol 2005，95 (7)：883-885., http://www.100md.com(李玲玲)